Anusha Jayaraman

Anusha Jayaraman

Auto-generated profile, based on publicly available information

Anusha Jayaraman

Department of Biochemistry and Molecular Biomedicine & Institute of Biomedicine of University of Barcelona, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2015 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
JAJoan Albert
Joan Albert
RBRamon Bosque
Ramon Bosque
MCMargarita Crespo
Margarita Crespo
JGJaume Granell
Jaume Granell
CLConcepción López
Concepción López
RMRamon Messeguer
Ramon Messeguer
The synthesis and preliminary biological evaluation of neutral and cationic platinum derivatives of chiral 1-(1-naphthyl)ethylamine are reported, namely cycloplatinated neutral complexes [PtCl{(R or S)-NH2CH(CH3)C10H6}(L)] [L = SOMe2 (1-R or 1-S), L = PPh3 (2-R or 2-S), L = P(4-FC6H4)3 (3-R), L = P(CH2)3N3(CH2)3 (4-R)], cycloplatinated cationic complexes [Pt{(R)-NH2CH(CH3)C10H6}{L}]Cl [L = Ph2PCH2CH2PPh2 (5-R), L = (C6F5)2PCH2CH2P(C6F5)2 (6-R)] and the Pt(II) coordination compound trans-[PtCl2{(R)-NH2CH(CH3)C10H6}2] (7-R). The X-ray molecular structure of 7-R is reported. The cytotoxic activity against a panel of human adenocarcinoma cell lines (A-549 lung, MDA-MB-231 and MCF-7 breast, and HCT-116 colon), cell cycle arrest and apoptosis, DNA interaction, topoisomerase I and cathepsin B inhibition, and Pt cell uptake of the studied compounds are presented. Remarkable cytotoxicity was observed for most of the synthesized Pt(II) compounds regardless of (i) the absolute configuration R or S, and (ii) the coordinated/cyclometallated (neutral or cationic) nature of the complexes. The most potent compound 2-R (IC50 = 270 nM) showed a 148-fold increase in potency with regard to cisplatin in HCT-116 colon cancer cells. Preliminary biological results point out to different biomolecular targets for the investigated compounds. Neutral cyclometallated complexes 1-R and 2-R, modify the DNA migration as cisplatin, cationic platinacycle 5-R was able to inhibit topoisomerase I-promoted DNA supercoiling, and Pt(II) coordination compound 7-R turned out to be the most potent inhibitor of cathepsin B. Induction of G-1 phase (2-R and 5-R), and S and G-2 phases (6-R) arrests are related to the antiproliferative activity of some representative compounds upon A-549 cells. Induction of apoptosis is also observed for 2-R and 6-R.

18 March 2014 in Organometallics
Verified
Journal Article
Closed access
AEAnna Escolà
Anna Escolà
MCMargarita Crespo
Margarita Crespo
JQJosefina Quirante
Josefina Quirante
RCRoldán Cortés
Roldán Cortés
AJAnusha Jayaraman
Anusha Jayaraman
MCMarta Cascante
Marta Cascante

1 November 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AEAnna Escolà
Anna Escolà
MCMargarita Crespo
Margarita Crespo
CLConcepción López
Concepción López
JQJosefina Quirante
Josefina Quirante
AJAnusha Jayaraman
Anusha Jayaraman
MCMARTA CASCANTE
MARTA CASCANTE

8 March 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
MCMei Chong
Mei Chong
AJAnusha Jayaraman
Anusha Jayaraman
SMSilvia Marin
Silvia Marin
VSVitaly Selivanov
Vitaly Selivanov
PCPedro R. de Atauri Carulla
Pedro R. de Atauri Carulla
CLChristian Ludwig
Christian Ludwig

1 September 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JAJoan Albert
Joan Albert
RBRamon Bosque
Ramon Bosque
MCMargarita Crespo
Margarita Crespo
GGGraciela García
Graciela García
JGJaume Granell
Jaume Granell
MCMARTA CASCANTE
MARTA CASCANTE

1 October 2014 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
IMIgor Marín de Mas
Igor Marín de Mas
EAEsther Aguilar
Esther Aguilar
AJAnusha Jayaraman
Anusha Jayaraman
IPIbrahim H Polat
Ibrahim H Polat
AMAlfonso Martín-Bernabé
Alfonso Martín-Bernabé
MCMARTA CASCANTE
MARTA CASCANTE
Metabolic processes are altered in cancer cells, which obtain advantages from this metabolic reprogramming in terms of energy production and synthesis of biomolecules that sustain their uncontrolle...